Let's Stand Up for Global Science

It is too early to calculate the full cost of these cuts in scientific knowledge, limits on access to research areas around the world, and U.S. leadership in global science activities. Nevertheless, it has plainly been substantial.

Written byEugene Garfield
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

As the U.S. pullout on December 31, 1984 approached, scientists worldwide worried about the impact that a 25 percent reduction in the UNESCO budget—the U.S. contribution—would have on the international Organization's science programs, as well as on U.S. scientific interests around the world. Stepping forward with reassurances at the time was then Assistant Secretary of State Gregory J. Newell, who indicated that the U.S.'s $47 million annual contribution to UNESCO, $14 million of which went to science, would be rechanneled to support comparable multinational work.

The State Department did recommend such allocations for fiscal year 1986, but the Reagan Administration's budget contained nothing in the way of UNESCO substitute funds. It was only through the last-minute efforts of William Salmon, then senior staff assistant at the State Department, that $2.75 million was penciled into the budget— almost all of it earmarked for science programs.

However, Congress, under pressure to reduce ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies